Table 6.

Overall impact of the MDR, n = 74

The MDR* has improved product traceability			Agree	Neither agree nor disagree	Disagree
Enterprise size	Micro	n	23	9	2
		%	67.6%	26.5%	5.9%
	Small	n	21	3	2
		%	80.8%	11.5%	7.7%
	Medium-sized	n	4	3	1
		%	50%	37.5%	12.5%
	Large	n	6	0	0
		%	100%	0%	0%
The MDR has improved patient safety
Enterprise size	Micro	n	23	4	7
		%	67.6%	11.8%	20.6%
	Small	n	20	3	3
		%	76.9%	11.5%	11.5%
	Medium-sized	n	5	3	0
		%	62.5%	37.5%	0%
	Large	n	6	0	0
		%	100%	0%	0%
The MDR has increased transparency
Enterprise size	Micro	n	21	8	5
		%	61.8%	23.5%	14.7%
	Small	n	22	1	3
		%	84.6%	3.8%	11.5%
	Medium-sized	n	3	3	2
		%	37.5%	37.5%	25%
	Large	n	5	0	1
		%	83.3%	0%	16.7%
The MDR guarantees fair market access for enterprises
Enterprise size	Micro	n	13	6	15
		%	38.2%	17.6%	44.1%
	Small	n	10	5	11
		%	38.5%	19.2%	42.3%
	Medium-sized	n	3	3	2
		%	37.5%	37.5%	25%
	Large	n	5	1	0
		%	83.3%	16.7%	0%

*MDR = Medical Device Regulation.

Note: Percentages may not total 100% due to rounding or multiple responses.